XLONAGR
Market cap1.55bUSD
Dec 24, Last price
37.98GBP
1D
1.50%
1Q
-9.18%
Jan 2017
-33.09%
IPO
-27.49%
Name
Assura PLC
Chart & Performance
Profile
Assura plc, a constituent of the FTSE 250 and the EPRA* indices, is a UK REIT and long-term investor in and developer of primary care property. The company, headquartered in Warrington, works with GPs, health professionals and the NHS to create outstanding spaces for health services in our communities. At 30 September 2020, Assura's property portfolio was valued at £2,259 million.
Valuation
Title GBP in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
---|---|---|---|---|---|---|---|---|---|---|
2024‑03 | 2023‑03 | 2022‑03 | 2021‑03 | 2020‑03 | 2019‑03 | 2018‑03 | 2017‑03 | 2016‑03 | 2015‑03 | |
Income | ||||||||||
Revenues | 157,800 3.82% | 152,000 10.71% | 137,300 13.47% | |||||||
Cost of revenue | 28,500 | 26,600 | 23,000 | |||||||
Unusual Expense (Income) | ||||||||||
NOPBT | 129,300 | 125,400 | 114,300 | |||||||
NOPBT Margin | 81.94% | 82.50% | 83.25% | |||||||
Operating Taxes | 100 | 700 | (100) | |||||||
Tax Rate | 0.08% | 0.56% | ||||||||
NOPAT | 129,200 | 124,700 | 114,400 | |||||||
Net income | (28,800) -75.84% | (119,200) -176.46% | 155,900 43.95% | |||||||
Dividends | (85,500) | (88,900) | (75,400) | |||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | (293,800) | |||||||||
BB yield | ||||||||||
Debt | ||||||||||
Debt current | 300 | 400 | 100 | |||||||
Long-term debt | 1,258,400 | 1,252,200 | 1,249,800 | |||||||
Deferred revenue | 4,200 | 35,700 | 36,100 | |||||||
Other long-term liabilities | 46,800 | 44,900 | ||||||||
Net debt | 1,205,800 | 1,116,300 | 1,002,600 | |||||||
Cash flow | ||||||||||
Cash from operating activities | 102,400 | 94,100 | 94,600 | |||||||
CAPEX | (2,800) | (15,200) | (3,500) | |||||||
Cash from investing activities | (97,700) | (130,400) | (293,900) | |||||||
Cash from financing activities | (87,300) | (89,200) | 396,200 | |||||||
FCF | 60,600 | 128,600 | 121,500 | |||||||
Balance | ||||||||||
Cash | 33,200 | 118,000 | 243,500 | |||||||
Long term investments | 19,700 | 18,300 | 3,800 | |||||||
Excess cash | 45,010 | 128,700 | 240,435 | |||||||
Stockholders' equity | 309,400 | 894,600 | 1,102,300 | |||||||
Invested Capital | 2,685,090 | 2,794,800 | 2,884,065 | |||||||
ROIC | 4.72% | 4.39% | 4.24% | |||||||
ROCE | 4.74% | 4.41% | 3.76% | |||||||
EV | ||||||||||
Common stock shares outstanding | 2,970,682 | 2,958,385 | 2,781,957 | |||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | 129,600 | 125,600 | 114,500 | |||||||
EV/EBITDA | ||||||||||
Interest | 27,100 | 31,200 | 30,000 | |||||||
Interest/NOPBT | 20.96% | 24.88% | 26.25% |